Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Development and Verification of a Full Physiologically Based Pharmacokinetic Model for Sublingual Buprenorphine in Healthy Adult Volunteers that Accounts for Nonlinear Bioavailability

Drug Metabolism and Disposition(2024)10.1124/dmd.124.001643Source: DataRank Database

Development and Verification of a Full Physiologically Based Pharmacokinetic Model for Sublingual Buprenorphine in Healthy Adult Volunteers that Accounts for Nonlinear Bioavailability is a research paper published in Drug Metabolism and Disposition (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 2.05)OA: bronzeTopics (42)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Ryota Tanaka ORCID,Trevor N. Johnson ORCID,Alexander A. Vinks ORCID,Tomoyuki Mizuno ORCID,Matthijs W. van Hoogdalem ORCID

Live enrichment

PubMed:38769016 OpenAlex:https://openalex.org/W4398133466

NICHD NIH HHS

Grant: P30 HD106451

NCATS NIH HHS

Grant: UL1 TR001425

FWCI

2.05

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

bronzeLicense: https://www.elsevier.com/legal/tdmrep-license

journalhttps://dmd.aspetjournals.org/content/dmd/early/2024/05/20/dmd.124.001643.full.pdf

publisherhttps://dmd.aspetjournals.org/content/dmd/early/2024/05/20/dmd.124.001643.full.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0090955624006688?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0090955624006688?httpAccept=text/plain

publisherhttps://syndication.highwire.org/content/doi/10.1124/dmd.124.001643

Fields of Study

Opioid Use Disorder TreatmentPrenatal Substance Exposure EffectsForensic Toxicology and Drug AnalysisHumansBuprenorphineAdministration, SublingualAdultModels, BiologicalBiological AvailabilityMaleFemaleHealthy VolunteersAnalgesics, OpioidYoung AdultArea Under CurveMiddle AgedDose-Response Relationship, DrugNonlinear Dynamics

MeSH Terms

Administration, SublingualAdultAnalgesics, OpioidBiological AvailabilityBuprenorphineDose-Response Relationship, DrugFemaleHumansMaleMiddle AgedModels, BiologicalNonlinear DynamicsArea Under CurveYoung AdultHealthy Volunteers

Keywords

BioavailabilityBuprenorphinePharmacologyPharmacokineticsMedicineAnesthesiaOpioidInternal medicineReceptor

Sustainable Development Goals

SDG 0: Good health and well-being